我国肝癌研究的现状与前景  

Research progress and prospect of liver cancer in China

作　　者：吕桂帅[1] 陈磊[1] 王红阳[1,2] 

机构地区：[1]第二军医大学东方肝胆外科医院,上海200438 [2]国家肝癌科学中心,上海201805

出　　处：《生命科学》2015年第3期237-248,共12页Chinese Bulletin of Life Sciences

摘　　要：肝癌是病死率最高的恶性肿瘤之一。我国每年约有38.3万人死于肝癌,占全球肝癌死亡病例数的51%,严峻的形势给我国的社会和医疗带来了沉重的负担。不断增加的科研经费投入为我国肝癌研究带来了快速发展的新机遇。主要介绍近年来我国科学家在肝癌流行病学、发病机制及诊疗方面取得的主要进展。Primary liver cancer is the leading cause of cancer-related mortality in China, with approximately 383 000 deaths annually, accounting for 51% of the mortality of liver cancer worldwide. It is a global burden for Chinese society and public health to face with this heavy situation. Chinese scientists are industriously unveiling the mechanisms of liver cancer with ever-accelerated science and technology. Here we summarize recent findings in the field of liver cancer research and outlook involving mechanism, diagnosis and therapy in China.

关 键 词：肝癌 发生机制 诊疗前景 

分 类 号：R735.7[医药卫生—肿瘤]